The Federal Circuit’s decision in Eye Therapies, LLC v. Slayback Pharma, LLC provides further insight into the tools available for patent claim construction. The Federal Circuit had previously held ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback